(MENAFN- Straits Research)
Market Overview
The North America aesthetic medicine market size was valued at USD 11.86 billion in 2025 and is projected to grow from USD 12.90 billion in 2026 to reach USD 25.34 billion by 2034, growing at a CAGR of 8.8% during the forecast period 2026–2034.
Aesthetic treatments, often known as cosmetic treatments, are non-surgical procedures that are intended to reduce the appearance of wrinkles, renew the skin, and make it look younger. Fine line and wrinkle reduction, fat reduction, stretch mark cures, scar therapy, skin oxygenation and resurrection, body contouring and firming botulinum toxin, and skin repair are all covered under medical aesthetics. Aesthetic medicine is primarily concerned with modifying a person's visual look to their liking. Scars, excess fat, skin discolouration, skin laxity, moles, and wrinkles are all treated with this procedure.
A variety of invasive, minimally invasive, and non-invasive cosmetic procedures are used in aesthetic medicine. The global medical aesthetics market is growing as the aged population becomes more aware of such treatments and accepts novel treatments. Furthermore, evolving consumer attitudes around wellness, beauty, and healthy aging have increased aesthetic awareness and acceptability, boosting demand from new patient categories like men and millennials.
Download a Free Sample To learn more about this report,
Market Dynamics
Market Drivers
The surge in demand for minimally invasive reconstruction surgeries, as well as an increase in traffic accidents and trauma cases, are propelling the medical aesthetics market forward. The significant prevalence of congenital face and teeth malformations also contributes to the market's overall growth.
Rising technology improvements and the expansion of awareness initiatives, such as the breast reconstructive awareness campaign, are likely to create profitable chances for the market.
The United States controls the majority of the cosmetic medicine market in North America. The need for cosmetic medications in North America is being driven by a rise in reconstructive treatments. The presence of advanced healthcare facilities and qualified specialists, as well as a high disposable income, are critical factors driving the growth of the aesthetic medicine business in North America.
According to the American Med Spa Association, the majority of medical spas in the United States provide at least one energy-based therapy, with almost 70% offering laser hair removal and around 54% offering body contouring. The demand for these treatments is expected to increase as a result of this. According to the 2020 Plastic Surgery Statistics Report, almost 4,401,536 botulinum toxin type A operations were performed in the United States, placing it among the top five non-surgical procedures. This is one of the world's most extensively used anti-wrinkle products.
Rhinoplasty, facelifts, neck lifts, eyelid surgery, and eye lifts have all seen a considerable increase in popularity. According to an Allergan poll conducted in April 2020, 95% of respondents said they planned to use a neurotoxic filler treatment once COVID-19 restrictions are lifted.
Non-invasive/minimally invasive fat reduction procedures increased by 7% in the United States between 2016 and 2019, according to the American Society of Plastic Surgeons (ASPS). Nearly 13.2 million minimally invasive surgical cosmetic procedures are expected to be performed in 2021. The aesthetic medicine sector is growing as a result of the growing popularity of minimally invasive procedures and the availability of a wide range of minimally invasive treatment options.
Market Restraints
The danger of complications linked with procedures and implants could pose a threat to the market's expansion. Additionally, The market's expansion is expected to be hampered by issues such as high treatment costs and inadequate reimbursements.
Due to increased internet purchases, the cosmeceuticals (self-care) market had a slight effect during the pandemic. Invasive and minimally invasive needs, such as aesthetic operations, saw a significant impact as a result of aesthetic facility closures and appointment postponement. The non-invasive market, which includes injectable fillers and laser-based cosmetic treatments, has experienced moderate-to-high consequences but is predicted to recover at a moderate-to-high rate.
The Federal Food, Drug and Cosmetic Act further restricts the usage of aesthetic medicines on various aspects. This acts as a major restraint for the aesthetic medicine market in the North American Region.
Private and government insurance policies may not cover all aesthetic operations. Methods primarily aimed to remove wrinkles, fats, hair removal, tattoo removal, removal of extra skin, and liposuction for the purpose of improving one's external appearance are not covered. Medicines include facial reconstructive after an accident and weight loss surgery to alleviate obesity-related concerns. The percentage of surgical treatments justified by medical reasons is smaller than the percentage of procedures undertaken for cosmetic reasons. As a result, a lack of reimbursement coverage for most operations may limit the market's total growth.
Market Opportunities
During the projected period, technological advancements provide attractive prospects for market participants. Furthermore, the critical need of optimising imaging workflows will boost the aesthetic medicine market's future growth rate.
North America Aesthetic Medicine Market Segmentation Analysis
By Procedure Type
The North America Aesthetic Medicine Market is segmented into Invasive Procedures and Non-invasive Procedures. Invasive procedures include surgical treatments such as liposuction, breast augmentation, rhinoplasty, eyelid surgery, facelifts, and other procedures requiring surgical intervention and specialized clinical facilities. Non-invasive procedures include botulinum toxin injections, dermal fillers, laser treatments, skin rejuvenation, body contouring, and other procedures involving limited or no surgical intervention. Invasive procedures maintain a significant position in the market due to established surgical infrastructure and high consumer demand for body and facial enhancement, while non-invasive procedures are increasingly preferred because of shorter recovery times, convenience, and comparatively lower procedural complexity.
Increasing consumer awareness, high disposable incomes, an aging population, technological advancements, and growing acceptance of aesthetic treatments are supporting demand across both procedure categories. The increasing preference for minimally invasive and non-invasive treatments is encouraging consumers to choose procedures with limited downtime and faster visible results, while continued improvements in surgical techniques and aesthetic technologies are supporting invasive procedures. The presence of experienced aesthetic professionals, advanced healthcare infrastructure, strong consumer spending on appearance-related services, and increasing influence of social media and beauty trends are further contributing to the expansion of both procedure segments across North America.
Request Customization to receive a tailored report.
By End Use
The North America Aesthetic Medicine Market is segmented into Hospitals, Clinics & Aesthetic Centers, and Medspas. Hospitals provide advanced infrastructure for complex surgical procedures and treatments requiring medical supervision, while clinics and aesthetic centers offer a broad range of invasive, minimally invasive, and non-invasive treatments, including injectables, laser procedures, skin rejuvenation, and body contouring. Medspas combine aesthetic treatments with wellness and personal-care services and provide consumers with convenient access to non-invasive and minimally invasive procedures. Clinics and aesthetic centers represent a major end-use category because of their specialized services, broad treatment portfolios, and accessibility to consumers.
Growing consumer preference for personalized aesthetic treatments, increasing availability of specialized facilities, rising demand for minimally invasive procedures, and continued technological development are supporting all three end-use segments. Hospitals continue to benefit from demand for complex surgical treatments and medically supervised procedures, while clinics and aesthetic centers are expanding their offerings to meet demand for faster and less invasive treatments. Medspas are also gaining popularity as consumers increasingly seek convenient aesthetic and wellness services in specialized settings. Rising disposable incomes, aging demographics, social media influence, celebrity and beauty trends, and continued innovation in aesthetic devices and injectables are expected to strengthen demand across hospitals, clinics and aesthetic centers, and medspas.
Speak to an Analyst to discuss market opportunities.
List of Key and Emerging Players in North America Aesthetic Medicine Market
Evolus Inc.
AIVITA Biomedical
Ellman International, Inc.
Genesis Biosystems, Inc.
Lumenis Ltd.
Sciton, Inc.
Wells Johnson Company
Zeltiq Aesthetics, Inc.
Key Industry Developments
June 2026: AbbVie expanded the North American aesthetic portfolio by introducing new AI-enabled digital tools to support treatment planning and patient consultation across its Allergan Aesthetics business.
April 2026: Galderma launched expanded indications and commercial initiatives for its injectable aesthetics portfolio across North America, strengthening facial aesthetics treatment offerings.
February 2026: Revance Therapeutics expanded commercialization of its DAXXIFY injectable treatment through strategic partnerships with aesthetic practices across the United States.
October 2025: Merz Aesthetics introduced new educational and physician training programs across North America to accelerate adoption of its facial aesthetics portfolio and injection techniques.
August 2025: Candela Corporation expanded its energy-based aesthetic device portfolio with new laser treatment technologies for skin rejuvenation and body contouring across North America.
Report Scope
Comments
No comment